作者：
Malorni, L. [1]
;
Curigliano, G. [2]
;
Minisini, A. M. [3]
;
Cinieri, S. [4]
;
Tondini, C. A. [5]
;
D'Hollander, K. [6]
;
Arpino, G. [7]
;
Bernardo, A. [8]
;
Martignetti, A. [9]
;
Criscitiello, C. [10]
;
Puglisi, F. [11]
;
Pestrin, M. [12]
;
Sanna, C. [13]
;
Moretti, E. ;
Risi, E. ;
Biagioni, C. ;
McCartney, A. ;
Boni, L. ;
Buyse, M. ;
Migliaccio, I. ;
Biganzoli, L. ;
Di Leo, A.
作者单位：
Univ Milan, Div Early Drug Dev, Dept Haematol & Haematooncol, Ist Europeo Oncol, Milan, Italy
[1]
Hosp Alta Val DElsa, Dept Oncol, Azienda USL Toscana Sud Est, Poggibonsi Siena, Italy
[2]
Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[3]
Hosp Prato, Sandro Pitigliani Med Oncol Dept, Via Suor Niccolina 20, I-59100 Prato, Italy
[4]
ASL Brindisi, Dept Med Oncol, Brindisi, Italy
[5]
Int Drug Dev Inst, San Francisco, CA USA
[6]
Hosp Papa Giovanni XXIII, Bergamo, Italy
[7]
Azienda Sanitaria Univ Integrata Udine, Dept Oncol, Udine, Italy
[8]
Int Drug Dev Inst, Louvain La Neuve, Belgium
[9]
ICS Maugeri IRCCS, Dept Med Oncol, Pavia, Italy
[10]
Ist Europeo Oncol, Div Early Drug Dev, Milan, Italy
[11]
Ist Toscano Tumori, Clin Trial Coordinating Ctr, AOU Careggi, Florence, Italy
[12]
CRO Natl Canc Inst, Med Oncol & Canc Prevent Unit, IRCCS, Aviano, Italy
[13]
发布时间
2019-03-17
换一批
换一批
